Crossmark

In silico analysis of balsaminol as anti-viral agents targeting SARS-CoV-2 main protease, spike receptor binding domain and papain-like protease receptors

Crossref DOI link: https://doi.org/10.1007/s40203-024-00241-0

Published Online: 2024-08-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gaiya, Daniel Danladi https://orcid.org/0000-0002-6905-2103
Muhammad, Aliyu https://orcid.org/0000-0002-4167-7793
Musa, Joy Sim

Auta, Richard

Dadah, Anthony John

Bello, Rachael Oluwafunmilayo

Hassan, Madinat https://orcid.org/0000-0001-7770-7037
Eke, Samuel Sunday

Odihi, Rebecca Imoo

Sankey, Musa
License Information

Text and Data Mining valid from 2024-08-16

Version of Record valid from 2024-08-16
More Information

Article History

Received: 9 October 2023

Accepted: 13 July 2024

First Online: 16 August 2024

Declarations

:

: The authors claim that the researchers in this study have no conflict of interest.

Document is current

Any future updates will be listed below